Martin Auster, Chief Financial Officer at Ventyx Biosciences (NASDAQ:VTYX), reported a large insider sell on September 7, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Auster sold 26,472 shares of Ventyx Biosciences. The total transaction amounted to $863,333.
Ventyx Biosciences shares are trading down 1.21% at $33.01 at the time of this writing on Friday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
Why Insider Transactions Are Important
Insider transactions shouldn't be used primarily to ...